The Switzerland stock market ended on a strong note on Thursday amid continued optimism about global economic recovery despite rising coronavirus cases and slow vaccination drive in several places across the world.
The benchmark SMI ended with a gain of 78.70 points or 0.71% at 11,206.88, the day’s high.
Partners Group shares gained nearly 2%. Givaudan climbed 1.7%, Roche Holding gained 1.65% and Alcon gained 1.57%. Nestle and SGS moved up by 1.2% and 1.1%, respectively.
ABB gained about 0.75% after launching a new share buyback program. Lonza Group, Sika and Novartis posted modest gains.
Swiss Life Holding, Zurich Insurance Group, Swatch Group and LafargeHolcim closed lower by 0.6 to 1%.
In the Mid Price Section, Lindt & Spruengli surged up 3.7% and Tecan Group gained 3.1%, while Straumann Holding, SIG Combibloc, VAT Group, Galenica Sante, Logitech and Temenos Group gained 1.3 to 2%.
Adecco, Barry Callebaut and Kuehne & Nagel also ended notably higher.
Among the losers, Dufry ended lower by about 3.3%, AMS shed nearly 2% and OC Oerlikon Corp lost 1.6%. Clariant, BB Biotech, Helvetia and Vifor Pharma ended down 0.9 to 1.1%.
Data released by Swiss National Bank showed foreign exchange reserves in Switzerland increased to CHF 930.48 billion in March from CHF 914.21 billion in February of 2021.
Market Analysis
Swiss Market Ends On Firm Note
2021-04-08 18:26:48
